KTTA•benzinga•
Pasithea Therapeutics: Safety Review Committee Recommends Its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 10, 2025 by benzinga